US HB1186 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on February 18 2021 - 25% progression, died in committee
Action: 2021-02-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 18 2021 - 25% progression, died in committee
Action: 2021-02-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes.
Title
Supply Chain Security and Pharmaceutical Authentication Act of 2021
Sponsors
| Rep. Jeff Van Drew [R-NJ] | Rep. James Baird [R-IN] | Sen. Markwayne Mullin [R-OK] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-02-19 | House | Referred to the Subcommittee on Health. |
| 2021-02-18 | House | Referred to the House Committee on Energy and Commerce. |
| 2021-02-18 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/1186/all-info |
| Text | https://www.congress.gov/117/bills/hr1186/BILLS-117hr1186ih.pdf |
